✨ Free AI Report
NeuroPace, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview NeuroPace, Inc.
Research Preview

NeuroPace, Inc.: Business Overview, Financials & Competitive Analysis

NeuroPace is a medical device company that develops the RNS System, a brain-responsive neuromodulation system delivering personalized, real-time treatment at the seizure source for treating drug-resistant focal epilep...

Analyst-debate audio for NeuroPace, Inc.

AskCyborg analysts argue the bull and bear cases for NeuroPace, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
NeuroPace, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
7/ 10Strong

Cyborg Score thesis

NeuroPace holds a unique, FDA-approved monopoly in closed-loop brain-responsive epilepsy treatment with accelerating revenue...

Read the full analyst-debate transcript →
Industry Medical Devices - Neuromodulation/Neurostimulation
2 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: June 15, 2026
AI-Verified Research
30+ Page Report

Get the Latest NeuroPace, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

NeuroPace, Inc. Overview

Pro stress-test →

NeuroPace is a medical device company that develops the RNS System, a brain-responsive neuromodulation system delivering personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. The RNS System is the first and only commercially available, brain-responsive neuromodulation device approved by the FDA for this indication.

Strategic Profile

Pro stress-test →

NeuroPace demonstrated 22% revenue growth to $79.9 million in 2024, driven by increased RNS System sales and contributions from a distribution agreement with DIXI Medical. The company operates the only FDA-approved closed-loop neuromodulation system, combining continuous intracranial EEG monitoring and targeted seizure interruption.

Competitive Landscape

Pro stress-test →

NeuroPace operates in a highly specialized market with minimal direct competition in closed-loop brain-responsive epilepsy treatment. Primary competitors include traditional neurosurgical approaches and alternative epilepsy treatments (medications, vagus nerve stimulation), but NeuroPace holds the only FDA-approved invasive responsive neuromodulation system for focal epilepsy. Potential future competitors may emerge in broader neuromodulation markets.

Industry Context

NeuroPace, Inc. operates in Medical Devices - Neuromodulation/Neurostimulation.

Key facts

Founded: 1997 · Headquarters: Mountain View, California · Revenue: $79.9B

What the analysts stress-tested

The top findings that survived the multi-agent debate for NeuroPace, Inc..

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when NeuroPace, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Vagus Nerve StimulationNon-responsive neuromodulation for epilepsy→Medical ManagementAnti-seizure medications and drug therapies→

Compare NeuroPace, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

NeuroPace, Inc. operates in Medical Devices - Neuromodulation/Neurostimulation. See how the rest of the sector scores on the Cyborg framework.

Browse Medical Devices - Neuromodulation/Neurostimulation research →
NEW · MCP server

Ask your AI assistant about NeuroPace, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare NeuroPace, Inc. and its top competitor on Cyborg Score”
“What did NeuroPace, Inc. do this quarter?”
“Is NeuroPace, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does NeuroPace, Inc. do?+
NeuroPace is a medical device company that develops the RNS System, a brain-responsive neuromodulation system delivering personalized, real-time treatment at the seizure source for treating drug-resistant focal epilep...
What is NeuroPace, Inc.'s Cyborg Score?+
NeuroPace, Inc. has a Cyborg Score of 7/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are NeuroPace, Inc.'s main competitors?+
Named competitors include Vagus Nerve Stimulation, Medical Management. The full competitive landscape is in the AskCyborg report.
How can I get the full NeuroPace, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the NeuroPace, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track NeuroPace, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

Other strong performers across the analyst-debate framework. Click any to see their research report.

9Phnom Penh Water Supply Authority9ESCO Technologies Inc.9Evolution Mining Limited9CoreWeave, Inc.9Nintendo Co., Ltd.9Waste Management, Inc.9CrowdStrike Holdings, Inc.9SK Hynix Inc.9Kweichow Moutai Co., Ltd.9Apple Inc.8Domino's Pizza, Inc.8Pro-Dex, Inc.8Palladyne AI Corp.8Mo-BRUK S.A.8Kuwait Reinsurance Company K.S.C.P.8Red River Bancshares, Inc.8PTC India Limited8IsoEnergy Ltd.